Where are you?
  • Austria
  • Belgium
  • Chile
  • Denmark
  • Finland
  • France
  • Germany
  • Guernsey
  • Ireland
  • Italy
  • Jersey
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Portugal
  • Singapore
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom
  • Rest of World
It looks like you’re in
Not your location?
And finally, please confirm the following details
I’m {role} in {country} and I agree to comply with the terms of the website.
You are viewing as from Change

Aitken Ross

Fund Manager, Sustainable Investment team

About Aitken

Aitken Ross is a fund manager who joined Liontrust in April 2017 as part of the company's acquisition of Alliance Trust Investments (ATI). Aitken started his career on the Alliance Trust Management Training programme in September 2010 after graduating in Accountancy and Finance (First Class Honours) from Dundee University and subsequently completing an MA in International Financial Analysis (Distinction) at Newcastle University. Following a successful period as an analyst within the team, Aitken became a named fund manager and is a CFA Charterholder.

Meet the tea

Latest insights

See all related
Peter Michaelis Peter Michaelis
Circular clothing: a sustainable approach to fashion A sustainable approach to fashion
icon 18 February 2025
Clothing
Linnea-Bengtsson Linnea Bengtsson
The future of data centres: Embracing liquid cooling technology The demand for more efficient and effective data centre cooling solutions has never been greater. Linnea Bengtsson explains why liquid cooling technology would revolutionize the way data centres manage heat dissipation.
icon 29 January 2025
Data centre
Peter Michaelis Peter Michaelis
What does Trump’s energy policy mean for investors? The outlook for renewables under the new US regime
icon 22 January 2025
	Renewable energy sources in fields
Lionesses Sarah Nottle & Martyn Jones
Biologics revolution: transforming drug delivery Biologics revolutionise treatment but pose challenges in delivery and transport
icon 8 January 2025
Biologics

Aitken's funds